Collaborative Cancer Epidemiology in the 21st Century: the Model of Cancer Consortia

Overview

Journal Cancer Epidemiol Biomarkers Prev

Specialties Biochemistry
Oncology
Public Health

Date 2013 Sep 19

PMID 24045926

Citations 10

Authors

Michael R Burgio

John P A Ioannidis

Brett M Kaminski

Eric DeRycke

Scott Rogers

Muin J Khoury

Daniela Seminara

Affiliations

Soon will be listed here.

Abstract

During the last two decades, epidemiology has undergone a rapid evolution toward collaborative research. The proliferation of multi-institutional, interdisciplinary consortia has acquired particular prominence in cancer research. Herein, we describe the characteristics of a network of 49 established cancer epidemiology consortia (CEC) currently supported by the Epidemiology and Genomics Research Program (EGRP) at the National Cancer Institute (NCI). This collection represents the largest disease-based research network for collaborative cancer research established in population sciences. We describe the funding trends, geographic distribution, and areas of research focus. The CEC have been partially supported by 201 grants and yielded 3,876 publications between 1995 and 2011. We describe this output in terms of interdisciplinary collaboration and translational evolution. We discuss challenges and future opportunities in the establishment and conduct of large-scale team science within the framework of CEC, review future prospects for this approach to large-scale, interdisciplinary cancer research, and describe a model for the evolution of an integrated Network of Cancer Consortia optimally suited to address and support 21st-century epidemiology.

Citing Articles

Data access arrangements in genomic research consortia.

Nicol D, Nielsen J, Archer M Sci Rep. 2024; 14(1):21685.

PMID: 39289472 PMC: 11408512. DOI: 10.1038/s41598-024-72653-z.

EU-US data transfers: an enduring challenge for health research collaborations.

Lalova-Spinks T, Valcke P, Ioannidis J, Huys I NPJ Digit Med. 2024; 7(1):215.

PMID: 39152232 PMC: 11329736. DOI: 10.1038/s41746-024-01205-6.

Moving Toward Findable, Accessible, Interoperable, Reusable Practices in Epidemiologic Research.

Garcia-Closas M, Ahearn T, Gaudet M, Hurson A, Balasubramanian J, Pal Choudhury P Am J Epidemiol. 2023; 192(6):995-1005.

PMID: 36804665 PMC: 10505418. DOI: 10.1093/aje/kwad040.

The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.

Nichols H, Schoemaker M, Wright L, McGowan C, Brook M, McClain K Cancer Epidemiol Biomarkers Prev. 2017; 26(9):1360-1369.

PMID: 28600297 PMC: 5581673. DOI: 10.1158/1055-9965.EPI-17-0246.

Ethics and Epistemology in Big Data Research.

Lipworth W, Mason P, Kerridge I, Ioannidis J J Bioeth Inq. 2017; 14(4):489-500.

PMID: 28321561 DOI: 10.1007/s11673-017-9771-3.

References

Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J . The Cancer Genetics Network: recruitment results and pilot studies. Community Genet. 2004; 6(3):171-7. DOI: 10.1159/000078165. View

Hunter D, Riboli E, Haiman C, Albanes D, Altshuler D, Chanock S . A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005; 5(12):977-85. DOI: 10.1038/nrc1754. View

Hindorff L, Sethupathy P, Junkins H, Ramos E, Mehta J, Collins F . Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009; 106(23):9362-7. PMC: 2687147. DOI: 10.1073/pnas.0903103106. View

Boffetta P, Colditz G, Potter J, Kolonel L, Robson P, Malekzadeh R . Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009). Cancer Causes Control. 2011; 22(3):463-8. PMC: 8933638. DOI: 10.1007/s10552-010-9717-0. View

Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso M, Rossi S . Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA. 2011; 305(1):59-67. PMC: 3690301. DOI: 10.1001/jama.2010.1919. View

Ragin C, Taioli E, McFarlane-Anderson N, Avery G, Bennett F, Bovell-Benjamin A . African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors. Infect Agent Cancer. 2007; 2:17. PMC: 2219955. DOI: 10.1186/1750-9378-2-17. View

Doherty R, Lubinski J, Manguoglu E, Luleci G, Christie M, Craven P . AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening. J BUON. 2007; 11(4):415-8. View

Wirtzfeld D, Mikula L, Gryfe R, Ravani P, Dicks E, Parfrey P . Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. Can J Surg. 2009; 52(2):92-7. PMC: 2663496. View

Mitra A, Bancroft E, Barbachano Y, Page E, Foster C, Jameson C . Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int. 2010; 107(1):28-39. PMC: 6057750. DOI: 10.1111/j.1464-410X.2010.09648.x. View

10.

Hoover R . The evolution of epidemiologic research: from cottage industry to "big" science. Epidemiology. 2006; 18(1):13-7. DOI: 10.1097/01.ede.0000249532.81073.b2. View

11.

Kastrinos F, Steyerberg E, Mercado R, Balmana J, Holter S, Gallinger S . The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology. 2010; 140(1):73-81. PMC: 3125673. DOI: 10.1053/j.gastro.2010.08.021. View

12.

Conway D, Hashibe M, Boffetta P, Wunsch-Filho V, Muscat J, La Vecchia C . Enhancing epidemiologic research on head and neck cancer: INHANCE - The international head and neck cancer epidemiology consortium. Oral Oncol. 2009; 45(9):743-6. DOI: 10.1016/j.oraloncology.2009.02.007. View

13.

Watkins K, Way C, Fiander J, Meadus R, Esplen M, Green J . Lynch syndrome: barriers to and facilitators of screening and disease management. Hered Cancer Clin Pract. 2011; 9:8. PMC: 3180430. DOI: 10.1186/1897-4287-9-8. View

14.

Rebbeck T, Paskett E, Sellers T . Fostering transdisciplinary science. Cancer Epidemiol Biomarkers Prev. 2010; 19(5):1149-50. DOI: 10.1158/1055-9965.EPI-10-0266. View

15.

Spurdle A, Healey S, Devereau A, Hogervorst F, Monteiro A, Nathanson K . ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat. 2011; 33(1):2-7. PMC: 3240687. DOI: 10.1002/humu.21628. View

16.

Boffetta P, Armstrong B, Linet M, Kasten C, Cozen W, Hartge P . Consortia in cancer epidemiology: lessons from InterLymph. Cancer Epidemiol Biomarkers Prev. 2007; 16(2):197-9. DOI: 10.1158/1055-9965.EPI-06-0786. View

17.

Jia W, Zhang B, Matsuo K, Shin A, Xiang Y, Jee S . Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet. 2012; 45(2):191-6. PMC: 3679924. DOI: 10.1038/ng.2505. View

18.

Freedman N, Murray L, Kamangar F, Abnet C, Cook M, Nyren O . Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut. 2011; 60(8):1029-37. PMC: 3439838. DOI: 10.1136/gut.2010.233866. View

19.

Cai Q, Long J, Lu W, Qu S, Wen W, Kang D . Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet. 2011; 20(24):4991-9. PMC: 3221542. DOI: 10.1093/hmg/ddr405. View

20.

Schully S, Benedicto C, Gillanders E, Wang S, Khoury M . Translational research in cancer genetics: the road less traveled. Public Health Genomics. 2010; 14(1):1-8. PMC: 3025883. DOI: 10.1159/000272897. View